Skip to content
Trial Eligibility
Menu

Adaptive Optics Retinal Imaging

NCT05370287

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The objective of the study is to collect and assess adaptive optics (AO) retinal images from human subjects in support of projects to demonstrate, advance, and enhance clinical use of AO technology.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Glaucoma, Primary Open Angle

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
21 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Food and Drug Administration (FDA)
Last updated on ClinicalTrials.gov
May 8, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • Food and Drug Administration · Silver Spring, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.